Federation Des Caisses Desjardins Du Quebec Regenxbio Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Aug 30, 2024
SELL
$30.19 - $40.28 $6,038 - $8,056
-200 Closed
0 $0
Q3 2021

Aug 30, 2024
BUY
$29.09 - $45.68 $5,818 - $9,136
200 New
200 $8.38 Million
Q1 2020

Aug 30, 2024
SELL
$21.5 - $54.2 $4,730 - $11,924
-220 Closed
0 $0
Q2 2019

Aug 30, 2024
SELL
$42.0 - $59.29 $89,880 - $126,880
-2,140 Reduced 90.68%
220 $11.3 Million
Q1 2019

Aug 30, 2024
BUY
$40.82 - $62.45 $96,335 - $147,382
2,360 New
2,360 $135 Million

Others Institutions Holding RGNX

# of Institutions
196
Shares Held
43M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $340M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email